Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Mallon Connor

13 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Receptor Pharmacology 5 Depression 5 OCD 4 Anxiety 4 In Vitro Study 3 Mechanism of Action 3 Clinical Trial 3 PTSD 3 Review Article 2 Neuroplasticity 2 Healthcare Workers 2 Pharmacology 2

Journals

Chembiochem: a European journal of chemical biology 3 Cureus 2 Value in Health 1 Journal of psychopharmacology (Oxford, England) 1 Comprehensive psychiatry 1 Journal of Labelled Compounds and Radiopharmaceuticals 1 Nature. Mental health 1 The Australian and New Zealand journal of psychiatry 1

Publication history

EE127 A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CAREValue in Health · 2026-06-01 Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis Volatilome.Chembiochem: a European journal of chemical biology · 2026-04-28 An exploration of the relationships between the effects of psilocybin on behavior, 5-HT receptor occupancy, and neuroplastic effects in mice.Journal of psychopharmacology (Oxford, England) · 2026-01-01 Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.Comprehensive psychiatry · 2025-10-01 Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe Metabolome.Chembiochem: a European journal of chemical biology · 2025-07-11 Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-07-01 Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01 Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01 Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer.Nature. Mental health · 2024-11-01 A "Magic Mushroom" Multi-Product Sesquiterpene Synthase.Chembiochem: a European journal of chemical biology · 2023-11-02 A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders.The Australian and New Zealand journal of psychiatry · 2023-03-01 Psilocybin-induced takotsubo cardiomyopathy.BMJ case reports · 2022-05-17 Can Psychedelics Radically Change SUD Treatment?Psychiatric News · 2020-03-20

Author directory